Volume 16, Issue 4 (Winter 2019)
Sci J Iran Blood Transfus Organ 2019, 16(4): 241-250 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Alaei M, Zadsar M, Pouriani E. The prevalence and probable risk factors of HbsAg positive blood donors in Mazandaran province in 2013. Sci J Iran Blood Transfus Organ 2019; 16 (4) :241-250
URL: http://bloodjournal.ir/article-1-1279-en.html
URL: http://bloodjournal.ir/article-1-1279-en.html
Full-Text [PDF 496 kb]
(1475 Downloads)
| Abstract (HTML) (2863 Views)
117-22.
The prevalence and probable risk factors of HbsAg positive
blood donors in Mazandaran province in 2013
Alaei M.1, Zadsar M.1, Aghaei A.1, Pouriani E.1,2
1Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
2Mazandaran Blood Transfusion Center, Sari, Iran
Abstract
Background and Objectives
HBV, a classic viral Transfusion Transmitted Infection(TTI), is considered an important health and blood safety issue in every society. Prevalence of HBsAg positivity is variable among Iranian blood donors nationwide. This study was performed to determine the frequency of HBsAg positive blood donors and the probable associated risk factors in Mazandaran province in 2013.
Materials and Methods
In this cross sectional descriptive study, demographic and donation data were gathered from IBTO data base (NEGARE). HBsAg positive donors were recalled for post test counseling and assessment of probable risk factors. SPSS 16 Chicago, χ2 and T-test were used as tools for data analysis.
Results
Among 131950 whole blood donors with mean age of 31.1 ± 9.5, 174(0.13%) proved to be HbsAg positive. Deferral rate was 16.6%. The highest and lowest positivity rates were observed at Babol and Galoogah, respectively. 95% of positive cases were detected among first time and male donors (p = 0.0001). Older age, lower education level, and first time donation were obtained as demographic risk factors primarily. No significant association between gender and marital status was found. However, post test counseling revealed non-immune dental procedures, high risk sexual contacts, cupping, family history of Hepatitis, hospital admission, tattooing, history of surgery, Intravenous Drug Use (IDU), endoscopic procedures, transfusion history and needle stick as risk factors in HBsAg positive donors.
Conclusions
HbsAg positivity rate in Mazandaran province donors is compatible with the country rate (0.13%). Main risk factors except gender and marital status are almost similar to other studies.
Key words: HBsAg, Blood Donors, Risk Factors, Blood Safety, Iran
Received: 2 Jun 2019
Accepted: 29 Sep 2019
Correspondence: Zadsar M., MD. Specialist in Infectious Diseases. Assistant Professor of Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine.
P.O.Box: 14665-1157, Tehran, Iran. Tel: (+9821) 82052234; Fax: (+9821) 88628741
E-mail:
Full-Text: (2818 Views)
References:
- Jaroszewicz J, Calle Serrano B, Wursthorn K, Deterding K, Schlue J, Raupach R, et al. Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: an European perspective. J Hepatol 2010; 52(4): 514-22.
- Saffar H, Ajami A, Saffar MJ, Shojaei J, Sotudeh-Anvari M, Shams-Esfandabad K, et al. Prevalence of hepatitis B virus seromarkers in young adults vaccinated at birth; impact on the epidemiology of hepatitis B infection in Iran. Hepat Mon 2014; 14(5): e17263.
- Esteve M, Loras C, González-Huix F. Lamivudine resistance and exacerbation of hepatitis B in infliximab-treated Crohn's disease patient. Inflamm Bowel Dis 2007; 13(11): 1450-1.
- Afzali M, Naderi H, Mirzaei M. Incidence rate of hepatitis B infection in provinces of Iran. Asian Pac J Trop Dis 2015; 5(9): 700-6.
- Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 2006; 28(1): 112-25.
- Hepatitis B fact sheet18 July 2018,online, Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b.
- World Health Organization. Hepatitis B vaccines. Geneva: World Health Organization; 2015. Available from:http://www.who.int/immunization/topics/WHO_position_paper_HepB.pdf.
- Weusten J, van Drimmelen H, Vermeulen M, Lelie N. A mathematical model for estimating residual transmission risk of occult hepatitis B virus infection with different blood safety scenarios. Transfusion 2017; 57(3pt2): 841-9.
- Li X, Zheng Y, Liau A, Cai B, Ye D, Huang F, et al. Hepatitis B virus infections and risk factors among the general population in Anhui Province, China: an epidemiological study. BMC Public Health 2012 ; 12(1): 272.
- Sood S, Malvankar S. Seroprevalence of Hepatitis B surface antigen, antibodies to the Hepatitis C virus, and human immunodeficiency virus in a hospital-based population in Jaipur, Rajasthan. Indian J Community Med 2010; 35(1): 165-9.
- World Health Organization. Combating hepatitis B and C to reach elimination by 2030: advocacy brief. World Health Organization; 2016.
- Poorolajal J, Majdzadeh R. Prevalence of chronic hepatitis B infection in Iran: a review article. J Res Med Sci 2009; 14(4): 249-58.
- Salehi-Vaziri M, Sadeghi F, Hashiani AA, Fesharaki MG, Alavian SM. Hepatitis B virus infection in the general population of Iran: an updated systematic review and meta-analysis. Hepat Mon 2016; 16(4): e35577.
- Almasi-Hashiani A, Ayubi E, Mansori K, Salehi-Vaziri M, Moradi Y, Gholamaliei B, et al. Prevalence of hepatitis B virus infection among Iranian high risk groups: a systematic review and meta-analysis. Gastroenterol Hepatol Bed Bench 2018; 11(2): 91-100.
- Vahid T, Alavian SM, Kabir A, Kafaee J, Yektaparast
117-22.
- Al-Waleedi AA, Khader YS. Prevalence of hepatitis B and C infections and associated factors among blood donors in Aden City, Yemen. East Mediterr Health J
- Hussein NR, Haj SM, Almizori LA, Taha AA. The prevalence of hepatitis B and C viruses among blood donors attending blood bank in Duhok, Kurdistan region, Iraq. Int J Infect 2017; 4(1): e39008.
- La Torre G, Saulle R. Risk factors from HBV infection among blood donors: A systematic review. Asian Pac J Trop Biomed 2016; 6(4): 344-9.
- Habte Y, Seyoum B, Alemayehu T. Hepatitis B virus infection and associated factors among blood donors at Dire Dawa, Eastern Ethiopia. J Antivir Antiretroviral 2016; 8: 4.
- Huang Y, Guo N, Yu Q, Lv Y, Ma H, Yun Z, et al. Risk factors for hepatitis B and C infection among blood donors in five Chinese blood centers. Transfusion 2015; 55(2): 388-94.
- Babanejad M, Izadi N, Najafi F, Alavian SM. The HBsAg Prevalence among blood donors from Eastern
Mediterranean and Middle Eastern countries: a systematic review and meta-Analysis. Hepat Mon 2016; 16(3): e35664. - Farshadpour F, Taherkhani R, Tajbakhsh S, Tangestani MG, Hajiani G, Sharifi N, et al. Prevalence and trends of transfusion-Transmissible viral infections among blood donors in south of Iran: An Eleven-Year retrospective study. PloS One 2016; 11(6): e0157615.
- Javadzadeh Shahshahani H, Vaziri M, Mansouri F. Seven years trends in prevalence of transfusion-transmissible viral infections in Yazd blood transfusion organization. Iran J Ped Hematol Oncol 2013; 3(3): 119-24.
- Mohsenizadeh M, Mollaei HR, Ghaziizadeh M. Seroepidemiological study of hepatitis B, C and HIV among blood donors in Kerman. Asian Pac J Cancer Prev 2017; 18(12): 3267-72.
|
Sci J Iran Blood Transfus Organ 2019;16 (4): 241-250 |
|
Original Article
|
The prevalence and probable risk factors of HbsAg positive
blood donors in Mazandaran province in 2013
Alaei M.1, Zadsar M.1, Aghaei A.1, Pouriani E.1,2
1Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
2Mazandaran Blood Transfusion Center, Sari, Iran
Abstract
Background and Objectives
HBV, a classic viral Transfusion Transmitted Infection(TTI), is considered an important health and blood safety issue in every society. Prevalence of HBsAg positivity is variable among Iranian blood donors nationwide. This study was performed to determine the frequency of HBsAg positive blood donors and the probable associated risk factors in Mazandaran province in 2013.
Materials and Methods
In this cross sectional descriptive study, demographic and donation data were gathered from IBTO data base (NEGARE). HBsAg positive donors were recalled for post test counseling and assessment of probable risk factors. SPSS 16 Chicago, χ2 and T-test were used as tools for data analysis.
Results
Among 131950 whole blood donors with mean age of 31.1 ± 9.5, 174(0.13%) proved to be HbsAg positive. Deferral rate was 16.6%. The highest and lowest positivity rates were observed at Babol and Galoogah, respectively. 95% of positive cases were detected among first time and male donors (p = 0.0001). Older age, lower education level, and first time donation were obtained as demographic risk factors primarily. No significant association between gender and marital status was found. However, post test counseling revealed non-immune dental procedures, high risk sexual contacts, cupping, family history of Hepatitis, hospital admission, tattooing, history of surgery, Intravenous Drug Use (IDU), endoscopic procedures, transfusion history and needle stick as risk factors in HBsAg positive donors.
Conclusions
HbsAg positivity rate in Mazandaran province donors is compatible with the country rate (0.13%). Main risk factors except gender and marital status are almost similar to other studies.
Key words: HBsAg, Blood Donors, Risk Factors, Blood Safety, Iran
Received: 2 Jun 2019
Accepted: 29 Sep 2019
Correspondence: Zadsar M., MD. Specialist in Infectious Diseases. Assistant Professor of Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine.
P.O.Box: 14665-1157, Tehran, Iran. Tel: (+9821) 82052234; Fax: (+9821) 88628741
E-mail:
|
1- Amaryam.zad@gmail.com
|
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
